Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Novo Nordisk to Double China R&D Headcount

publication date: Sep 14, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Novo Nordisk will expand its Beijing R&D center from 100 employees currently to 200 by 2015. The expansion will create a new Diabetes Research Unit, capable of performing all stages of drug development. At the same time, the company said it expects its China sales to grow at the same 20% annual rate as China healthcare spending, which will take its revenues in China to $1.75 billion by 2015. More details....

Stock Symbol: (NYSE: NVO)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners